The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The gene symbol MESK2 is correctly matched here to Drosophila melanogaster CG15669 and UniProt Q8T0V2. The literature explicitly refers to CG15669 (Mesk2), consistent with the organism and identifiers supplied in the query; evidence concerning similarly named genes in other species was excluded. The protein’s NDRG-family and α/β-hydrolase-fold annotations are also mutually consistent. (molnar2006againoffunctionscreen pages 16-17)
Nevertheless, the literature is limited for this specific protein. No study located through 2024 establishes a catalytic reaction, substrate, ligand, direct binding partner, or subcellular compartment for MESK2. The best-supported physiological result is that glial depletion of MESK2 impairs circadian locomotor rhythmicity. Earlier gain-of-function screens show that MESK2 overexpression can modify Ras1/KSR-dependent eye phenotypes and may affect wing differentiation, but neither screen defines its endogenous molecular mechanism. (huang2000amisexpressionscreen pages 4-5, huang2000amisexpressionscreen pages 5-7, you2018regulationofcircadian pages 9-11, molnar2006againoffunctionscreen pages 16-17)
The 2006 wing-screen paper explicitly lists CG15669 (Mesk2), providing an independent literature bridge between the systematic locus and gene symbol. The original 2000 study used the operational name MESK2, meaning “modifier/enhancer of suppressor of KSR,” for one of four misexpression loci recovered from a Ras-pathway screen. (huang2000amisexpressionscreen pages 5-7, molnar2006againoffunctionscreen pages 16-17)
No conflicting organism-specific identity was found. Importantly, MESK2 must not be confused with MESR2, another locus discussed in early Drosophila genetic work, or with mammalian NDRG paralogs. The 2000 paper’s described wing phenotype for MESR2 cannot be assigned to MESK2. (huang2000amisexpressionscreen pages 7-8)
There is presently no demonstrated enzymatic activity for purified MESK2. No reaction, substrate specificity, kinetic constant, catalytic residue, metabolite product, transporter substrate, or direct molecular interaction has been reported in the retrieved gene-specific literature. The available experiments are genetic rather than biochemical. (huang2000amisexpressionscreen pages 4-5, you2018regulationofcircadian pages 9-11, molnar2006againoffunctionscreen pages 16-17)
An α/β-hydrolase fold is a structural architecture, not proof that a protein is an active hydrolase. Recent NDRG-family structural interpretation reports that the conserved NDR domain adopts an α/β-hydrolase-like fold while substitutions at the expected catalytic positions—reported as S→G, D→S and H→G—remove the canonical catalytic set. This supports classification of NDRG proteins as likely nonenzymatic, hydrolase-fold regulatory proteins rather than esterases or lipases. (komorowska2024moleculardissectionof pages 29-32)
Earlier NDRG2 structural analysis likewise found an α/β-hydrolase-like and cap-domain architecture but no recognizable nucleophile–acid–histidine catalytic triad. Thus, the strongest family-level expectation is that MESK2 functions through protein interactions, conformational regulation, or scaffolding rather than catalysis. However, catalytic inactivity has not been tested directly for recombinant MESK2, and functions assigned to mammalian NDRG1–4 cannot automatically be transferred to the fly protein because NDRG terminal regions and paralog-specific biology diverge. (komorowska2024moleculardissectionof pages 29-32, yao2008ndrg2amyc‐repressed pages 1-2)
Functional-annotation recommendation: describe MESK2 as an NDRG-family α/β-hydrolase-like protein of unknown molecular activity, not as a hydrolase enzyme. Its substrate should be recorded as unknown/not applicable pending evidence.
Huang and Rubin’s study, published November 2000, used dominant-negative Kinase Suppressor of Ras (KSR) and activated Ras1 rough-eye backgrounds to find modifiers of Sevenless/Ras/MAPK signaling. The MESK2-associated EP(2)2347 misexpression line suppressed the dominant-negative KSR phenotype and enhanced the activated Ras1 phenotype. Operationally, this pattern is consistent with increased or facilitated pathway output when MESK2 is overexpressed. The paper also assessed effects on R7 photoreceptor fate within the screen. [DOI/URL: https://doi.org/10.1093/genetics/156.3.1219] (huang2000amisexpressionscreen pages 4-5, huang2000amisexpressionscreen pages 5-7)
This is a genetic interaction, not biochemical pathway placement. It does not show that endogenous MESK2 is required for Ras signaling, that MESK2 directly binds Ras/KSR/MAPK components, or where it acts relative to those proteins. Gain-of-function effects can arise through parallel pathways, dosage artifacts, or general effects on differentiation. Accordingly, MESK2 is best described as a candidate modulator of Ras-dependent developmental signaling under overexpression conditions, not an established core Ras-pathway component. (huang2000amisexpressionscreen pages 4-5, huang2000amisexpressionscreen pages 7-8)
The strongest loss-of-function evidence comes from You et al., published March 2018. After computationally predicting miR-274 targets and intersecting them with astrocyte-enriched transcripts, the investigators tested candidate genes with glial RNAi. Two independent MESK2 RNAi transgenes significantly reduced locomotor rhythmicity relative to the RNAi control, with P < 0.0001. This replication across independent constructs supports a functional requirement for MESK2 in glial cells for normal circadian behavior, although no RNAi-resistant rescue was reported. [DOI/URL: https://doi.org/10.1534/genetics.117.300342] (you2018regulationofcircadian pages 9-11, you2018regulationofcircadian pages 1-2)
MESK2 was tested as a possible target of astroglial miR-274. RT-qPCR used RNA from samples of 5–10 pharate-adult pupae, MESK2-specific primers, and rp49 as reference. Following glial miR-274 overexpression, MESK2 RNA displayed only a nonsignificant downward trend with n = 4–7. Therefore, the study did not demonstrate direct miR-274 repression of MESK2, nor did it establish that altered MESK2 expression mediates the miR-274 circadian phenotype. A 3′-UTR reporter, target-site mutagenesis, and genetic rescue would be needed for that conclusion. (you2018regulationofcircadian pages 9-11, you2018regulationofcircadian pages 11-12, you2018regulationofcircadian pages 2-3)
Molnar et al., published November 2006, identified insertion EP-634.2 in a wing gain-of-function screen. The insertion was mapped to cytological region 57E8 and associated with CG15669/Mesk2 in a cell-differentiation phenotype class; the table recorded phenotypic codes “N, V” and “Mq” in different Gal4 assays. [DOI/URL: https://doi.org/10.1534/genetics.106.061283] (molnar2006againoffunctionscreen pages 16-17)
This evidence is weak for assigning a wing mechanism to MESK2. The insertion had another candidate gene, and no Mesk2-specific cDNA validation, loss-of-function test, rescue, quantitative phenotype, or molecular pathway analysis was reported in the relevant evidence. It should therefore be treated as a screen-level association, not proof that MESK2 directly controls vein formation. (molnar2006againoffunctionscreen pages 16-17)
The available evidence supports a cellular context, but not a protein compartment:
Consequently, the appropriate annotation is intracellular location unknown; functional evidence in glial cells, rather than a specific organelle assignment.
| Topic | Exact finding | Evidence type | Confidence / limitation |
|---|---|---|---|
| Identity | Target is Drosophila melanogaster MESK2, also designated CG15669 and associated with UniProt Q8T0V2; the literature explicitly identifies CG15669 as Mesk2. (molnar2006againoffunctionscreen pages 16-17) | Database identity supplied in the query; literature cross-reference | High for organism and identifier mapping; do not conflate with similarly named genes in other organisms. |
| Protein family and fold | MESK2 is annotated as an NDRG-family, α/β-hydrolase-like protein. NDRG-family structures retain this fold but lack the canonical hydrolase catalytic residues, supporting likely catalytic inactivity. (komorowska2024moleculardissectionof pages 29-32, yao2008ndrg2amyc‐repressed pages 1-2) | Domain annotation plus family-level sequence/structural inference | Moderate for MESK2; catalytic inactivity has not been tested directly on purified MESK2. |
| Biochemical function | No catalyzed reaction, substrate specificity, binding partner, or direct molecular activity has been established for MESK2. | Evidence-gap assessment | High confidence that the available gene-specific studies do not define these properties; the fold alone must not be treated as proof of hydrolase activity. |
| Ras/KSR signaling | The MESK2-associated misexpression line suppressed the dominant-negative KSR rough-eye phenotype and enhanced the activated Ras1 phenotype, showing that overexpression can increase or facilitate Ras-pathway output in this assay. (huang2000amisexpressionscreen pages 4-5, huang2000amisexpressionscreen pages 5-7) | Gain-of-function genetic interaction screen | Moderate screen-level evidence; does not establish endogenous pathway placement, direct biochemical action, or physiological necessity. |
| Wing development | In a 2006 gain-of-function wing screen, insertion EP-634.2 was associated with CG15669/Mesk2 and classified among cell-differentiation phenotypes, with recorded phenotypic codes “N, V” and “Mq.” (molnar2006againoffunctionscreen pages 16-17) | Insertion-based gain-of-function screen | Low; the insertion also had another candidate gene, and no Mesk2-specific validation, rescue, or loss-of-function follow-up was reported. |
| Glial circadian function | Glial knockdown using two independent MESK2 RNAi transgenes significantly reduced locomotor rhythmicity relative to the RNAi control (P < 0.0001). (you2018regulationofcircadian pages 9-11) | Cell-type-directed loss-of-function RNAi | Moderate-to-strong genetic evidence that glial MESK2 supports normal rhythmicity; absence of rescue and possible RNAi limitations prevent definitive molecular assignment. |
| Proposed miR-274 regulation | After glial miR-274 overexpression, MESK2 RNA showed a downward trend that was not statistically significant (n = 4–7). (you2018regulationofcircadian pages 9-11, you2018regulationofcircadian pages 11-12) | Target prediction followed by pupal RT-qPCR | Low; direct miR-274 targeting and mediation of the circadian phenotype were not demonstrated. |
| Cellular location | Astroglial RNAi establishes a functional requirement in glial cells under the assay conditions, but the subcellular location of MESK2 protein remains unknown. (you2018regulationofcircadian pages 9-11, you2018regulationofcircadian pages 11-12) | Cell-type-specific genetics; no direct localization assay | Moderate for a glial functional context; no microscopy, fractionation, or endogenous protein-localization evidence defines its intracellular compartment. |
| 2023–2024 developments | No 2023–2024 MESK2-specific mechanistic study was identified; recent information is limited to family-level NDRG structural interpretation rather than direct work on fly MESK2. (komorowska2024moleculardissectionof pages 29-32) | Literature-search assessment and family-level 2024 evidence | The negative search result is database- and query-dependent and should not be interpreted as proof that no unpublished or unindexed work exists. |
Table: This table separates direct findings for Drosophila MESK2/CG15669/Q8T0V2 from screen associations, family-level inference, and unresolved questions. It highlights that glial circadian genetics is the strongest gene-specific evidence, whereas biochemical activity and subcellular localization remain unknown.
No 2023–2024 publication was identified that directly resolved MESK2 biochemistry, structure, localization, or endogenous pathway placement. The relevant 2024 material is family-level work reinforcing that NDRG proteins are catalytically inactive α/β-hydrolase-like proteins; it does not experimentally characterize fly MESK2. (komorowska2024moleculardissectionof pages 29-32)
MESK2 currently has no clinical or industrial implementation. Its real-world use is as a research target in Drosophila genetics: candidate modifier of Ras-associated developmental phenotypes, candidate wing-development locus, and glial factor needed for robust locomotor rhythms. The circadian RNAi result is the most directly reproducible gene-specific observation, while the older Ras and wing findings mainly generate mechanistic hypotheses. (huang2000amisexpressionscreen pages 5-7, you2018regulationofcircadian pages 9-11, molnar2006againoffunctionscreen pages 16-17)
The current evidence does not justify assigning MESK2 a precise enzymatic or signaling mechanism. The most defensible working model is that MESK2 is a noncatalytic NDRG-fold regulatory protein whose expression in glia supports circadian network function and whose overexpression can alter developmental signaling outputs. Whether the glial and Ras-associated observations reflect one molecular activity is unknown.
High-priority experiments are: (1) a clean CRISPR null and endogenous-tagged allele; (2) cell-type-specific rescue of circadian rhythmicity; (3) endogenous protein localization in adult astrocyte-like glia; (4) direct miR-274 3′-UTR reporter and target-site editing; (5) quantitative phospho-ERK assays under MESK2 loss and gain of function; (6) affinity-purification or proximity-labeling interactomics; and (7) recombinant structural/biochemical analysis to verify catalytic inactivity. These studies would distinguish an NDRG-like scaffold or adaptor role from indirect transcriptional or metabolic effects.
MESK2/CG15669/Q8T0V2 is correctly identified as a D. melanogaster NDRG-family protein, but remains mechanistically undercharacterized. No catalytic reaction or substrate is known, and the family’s disrupted catalytic triad argues against annotating it as an active hydrolase. Direct genetic evidence indicates that glial MESK2 supports circadian rhythmicity; gain-of-function evidence suggests the capacity to modulate Ras/KSR-associated eye signaling and wing differentiation. Its direct partners, endogenous pathway position, and subcellular localization remain unresolved. (huang2000amisexpressionscreen pages 5-7, you2018regulationofcircadian pages 9-11, molnar2006againoffunctionscreen pages 16-17, komorowska2024moleculardissectionof pages 29-32)
References
(molnar2006againoffunctionscreen pages 16-17): Cristina Molnar, Ana López-Varea, Rosario Hernández, and Jose F de Celis. A gain-of-function screen identifying genes required for vein formation in the drosophila melanogaster wing. Genetics, 174:1635-1659, Nov 2006. URL: https://doi.org/10.1534/genetics.106.061283, doi:10.1534/genetics.106.061283. This article has 59 citations and is from a domain leading peer-reviewed journal.
(huang2000amisexpressionscreen pages 4-5): Audrey M Huang and Gerald M Rubin. A misexpression screen identifies genes that can modulate ras1 pathway signaling in drosophila melanogaster. Genetics, 156(3):1219-1230, Nov 2000. URL: https://doi.org/10.1093/genetics/156.3.1219, doi:10.1093/genetics/156.3.1219. This article has 143 citations and is from a domain leading peer-reviewed journal.
(huang2000amisexpressionscreen pages 5-7): Audrey M Huang and Gerald M Rubin. A misexpression screen identifies genes that can modulate ras1 pathway signaling in drosophila melanogaster. Genetics, 156(3):1219-1230, Nov 2000. URL: https://doi.org/10.1093/genetics/156.3.1219, doi:10.1093/genetics/156.3.1219. This article has 143 citations and is from a domain leading peer-reviewed journal.
(you2018regulationofcircadian pages 9-11): Samantha You, Tudor A Fulga, David Van Vactor, and F Rob Jackson. Regulation of circadian behavior by astroglial micrornas indrosophila. Mar 2018. URL: https://doi.org/10.1534/genetics.117.300342, doi:10.1534/genetics.117.300342. This article has 52 citations and is from a domain leading peer-reviewed journal.
(huang2000amisexpressionscreen pages 7-8): Audrey M Huang and Gerald M Rubin. A misexpression screen identifies genes that can modulate ras1 pathway signaling in drosophila melanogaster. Genetics, 156(3):1219-1230, Nov 2000. URL: https://doi.org/10.1093/genetics/156.3.1219, doi:10.1093/genetics/156.3.1219. This article has 143 citations and is from a domain leading peer-reviewed journal.
(komorowska2024moleculardissectionof pages 29-32): J Komorowska. Molecular dissection of ndrg3 function in t cell development and homeostasis. Unknown journal, 2024.
(yao2008ndrg2amyc‐repressed pages 1-2): L Yao, J Zhang, and X Liu. Ndrg2: a myc‐repressed gene involved in cancer and cell stress. Unknown journal, 2008. URL: https://doi.org/10.1111/j.1745-7270.2008.00434, doi:10.1111/j.1745-7270.2008.00434.
(you2018regulationofcircadian pages 1-2): Samantha You, Tudor A Fulga, David Van Vactor, and F Rob Jackson. Regulation of circadian behavior by astroglial micrornas indrosophila. Mar 2018. URL: https://doi.org/10.1534/genetics.117.300342, doi:10.1534/genetics.117.300342. This article has 52 citations and is from a domain leading peer-reviewed journal.
(you2018regulationofcircadian pages 11-12): Samantha You, Tudor A Fulga, David Van Vactor, and F Rob Jackson. Regulation of circadian behavior by astroglial micrornas indrosophila. Mar 2018. URL: https://doi.org/10.1534/genetics.117.300342, doi:10.1534/genetics.117.300342. This article has 52 citations and is from a domain leading peer-reviewed journal.
(you2018regulationofcircadian pages 2-3): Samantha You, Tudor A Fulga, David Van Vactor, and F Rob Jackson. Regulation of circadian behavior by astroglial micrornas indrosophila. Mar 2018. URL: https://doi.org/10.1534/genetics.117.300342, doi:10.1534/genetics.117.300342. This article has 52 citations and is from a domain leading peer-reviewed journal.